KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $11.03 $12.67 Friday, 26th Apr 2024 DVAX stock ended at $11.21. This is 0.358% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.09% from a day low at $11.03 to a day high of $11.26.
90 days $11.03 $13.41
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Dec 06, 2021 $13.02 $13.48 $12.60 $13.39 5 003 488
Dec 03, 2021 $14.25 $14.25 $12.82 $13.17 4 392 000
Dec 02, 2021 $15.08 $15.33 $14.40 $14.70 2 220 326
Dec 01, 2021 $15.95 $16.41 $15.10 $15.11 1 580 921
Nov 30, 2021 $15.94 $16.34 $15.23 $16.15 2 068 831
Nov 29, 2021 $16.78 $17.11 $16.02 $16.07 2 921 754
Nov 26, 2021 $17.08 $17.18 $15.98 $16.32 1 774 424
Nov 24, 2021 $15.94 $16.49 $15.60 $16.39 1 293 016
Nov 23, 2021 $16.20 $16.47 $15.45 $15.80 2 042 872
Nov 22, 2021 $16.37 $16.64 $15.71 $16.26 2 769 347
Nov 19, 2021 $16.63 $17.13 $16.47 $16.47 2 824 404
Nov 18, 2021 $17.03 $17.51 $16.47 $16.75 1 735 248
Nov 17, 2021 $17.13 $17.43 $16.75 $16.96 2 320 676
Nov 16, 2021 $16.93 $17.58 $16.77 $17.16 1 828 720
Nov 15, 2021 $16.99 $17.47 $16.80 $17.05 1 134 427
Nov 12, 2021 $16.37 $17.10 $16.36 $16.95 2 237 615
Nov 11, 2021 $16.02 $16.48 $15.75 $16.41 2 984 633
Nov 10, 2021 $16.50 $17.00 $15.95 $16.02 2 635 030
Nov 09, 2021 $16.32 $16.47 $15.75 $15.97 1 821 783
Nov 08, 2021 $16.51 $17.12 $15.98 $16.13 2 807 934
Nov 05, 2021 $18.16 $18.63 $14.90 $16.16 10 619 511
Nov 04, 2021 $21.37 $21.39 $20.55 $20.76 4 957 708
Nov 03, 2021 $20.59 $21.11 $20.22 $20.94 2 262 658
Nov 02, 2021 $20.60 $20.67 $20.05 $20.54 1 485 954
Nov 01, 2021 $20.12 $21.14 $19.64 $20.56 3 286 168
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT